Subscribe Login
A-Brands

J&J Starts Share Exchange Offer For Consumer Health Spin-Off Kenvue

By Donna Ahern
J&J Starts Share Exchange Offer For Consumer Health Spin-Off Kenvue

Johnson & Johnson said on Monday that it had launched an exchange offer under which its stockholders can opt for shares of Kenvue, its newly listed consumer health unit.

J&J, which currently owns an 89.6% stake in Kenvue, said it intends to split off at least 80.1% of the consumer health company's shares as part of the offering.

The offering will help J&J move a step closer in its plan to spin off the unit and focus on its larger medical devices and pharmaceuticals businesses.

The exchange will allow J&J shareholders to exchange their shares for those of Kenvue at a 7% discount, subject to conditions.

Kenvue, which debuted on the New York Stock Exchange in May, has a market capitalisation of about $46 billion.

ADVERTISEMENT

The offering comes days after J&J and Kenvue both forecast strong profit for this year.

‍Goldman Sachs and J.P. Morgan Securities are serving as dealer managers for the offering, J&J said.

J&J shares rose about 1% in premarket trading.

Full-Year Profit

On 21 July, Kenvue, the former consumer health unit of Johnson & Johnson, forecast full-year profit above Wall Street estimates, betting on resilient demand for its skincare and self-care products, such as Neutrogena and Tylenol.

ADVERTISEMENT

Shares of the company still fell as much as 10% after J&J, which owns 90% of Kenvue's outstanding shares, said a tender offer to sell the stake could start as early as the coming days.

The timing of the tender offer "was earlier than expected" because there was a 180-day lockup following Kenvue's initial public offering (IPO) in May, said Navann Ty, an analyst at BNP Paribas Exane. Typically, company insiders cannot sell shares during the IPO lock-up period.

Kenvue, in its first results announcement after going public, forecast annual adjusted profit per share between $1.26 and $1.31, above analysts' expectations of $1.23, according to Refinitiv.

Read More: J&J Spinoff Kenvue Forecasts Upbeat Annual Profit On Self-Care Boost

News by Reuters, edited by Donna Ahern, Checkout. For more A-brand news, click here. Click subscribe to sign up for the Checkout print edition.

Stay Connected With Our Weekly Newsletter

Processing your request...

Thanks! please check your email to confirm your subscription.